Read our blog posts below.
GLP-1s have moved far beyond weight loss. Here’s what the latest research shows about their effects on heart, kidneys, liver, sleep, brain, and cravings.
Competing on price attracts the wrong clients. See how wellness business owners use premium positioning and clinical value to grow revenue and retention.
Women have more testosterone than estrogen, but testosterone for women is barely tested or treated. Here’s why that’s about to change.
Sourcing GLP-1s in 2026 looks very different than it did two years ago. Here’s how to navigate the new legal landscape, and what to ask a potential pharmacy partner.
The FDA’s advisory panel just voted on BPC-157 and six other peptides. Here’s what happened.
Peptides are everywhere in wellness — from GLP-1s to BPC-157. Here’s what they are, why they’re trending, and what the clinical evidence shows.
Lyv Health is now Altro Health, the same team and mission with a name that reflects where we're going: giving wellness businesses the clinical infrastructure to offer labs, prescriptions, and more under their own brand, and grow.